A retrospective single-centered, comprehensive targeted genetic sequencing analysis of prognostic survival using tissues from Korean patients with metastatic renal cell carcinoma after targeted therapy-Reference-Cited by-同舟云学术

A retrospective single-centered, comprehensive targeted genetic sequencing analysis of prognostic survival using tissues from Korean patients with metastatic renal cell carcinoma after targeted therapy

Published:2022 Issue:6 Volume:63 Page:602
ISSN:2466-0493
Container-title:Investigative and Clinical Urology
language:en
Short-container-title:Investig Clin Urol

Author:

Kim Sung Han¹^ORCID,Park Jongkeun²^ORCID,Park Weon Seo³^ORCID,Hong Dongwan²^ORCID,Chung Jinsoo¹^ORCID

Affiliation:

1. Department of Urology, Urologic Cancer Center, National Cancer Center, Goyang, Korea.

2. Department of Medical Informatics, College of Medicine, The Catholic University of Korea, Seoul, Korea.

3. Department of Pathology, Urologic Cancer Center, National Cancer Center, Goyang, Korea.

Funder

National Cancer Center

National Research Foundation of Korea

Catholic Medical Center Research Foundation

Publisher

The Korean Urological Association

Subject

Urology

Link

https://icurology.org/pdf/10.4111/icu.20210341

Reference29 articles.

1. Renal cell carcinoma

2. National Comprehensive Cancer Network. NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines). Kidney Cancer. Version 1.2020 [Internet]. Plymouth Meeting. National Comprehensive Cancer Network. 2019. cited 2021 Sep 14. Available from: https://www.nccn.org/professionals/physician_gls/PDF/kidney.pdf

3. EAU Guideline v2019. Oncology Guideline. Renal Cell Carcinoma. Chapter 7. Disease Management. 7.4 Systemic therapy for advanced/metastatic RCC [Internet]. Arnhem. EAU Guidelines Office. 2022. cited 2021 Sep 14. Available from: https://uroweb.org/guideline/renal-cell-carcinoma

4. Clinical correlates and prognostic value of different metastatic sites in metastatic renal cell carcinoma